Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: a subanalysis from a phase 3 trial (MPACT)

Arndt Vogel, Michael Ståhl, Josefine Römmler-Zehrer et al.|BMC Cancer|2016

Cited by 36